跳至主要内容
临床试验/NCT01534442
NCT01534442Unknown不适用

The Significances of Atropin Administration for the GLP-1 Potentiation of Glucose Induced Insulin Secretion and the Cephalic Insulin Response

University Hospital, Gentofte, Copenhagen2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2011年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
10
试验地点
2
主要终点
insulin secretion

研究概览

简要总结

The aim of this study is to investigate the role of transmission of vagal cholinerg for the GLP-1 potentiation of the glucose stimulated insulin secretion and the cephalic insulin response by using atropin administration.

The hypothesis is that a great deal of the effects of GLP-1 is mediated via the nervous system and for this reason the investigators will research individuals with an intact nervous supply with and without atropin administration.

详细描述

GLP-1 is a importent enterogastron and incretin hormone. Rapid degradation of GLP-1 by dipeptidyl peptidase 4 (DPP-4) suggests that GLP-1 may act locally (through vagal afferents) before being degraded. We aimed to clarify the role of vagal innervation on the incretin effect.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • age between 18 and 45 years
  • normal fasting plasma glucose
  • normal hemoglobin
  • informed consent

排除标准

  • diabetes mellitus
  • body mass index above 30
  • inflamatoric bowel disease
  • intestinal surgery
  • serum creatinine above 250 microM
  • ALAT above to times normal value
  • treatment with medicine wich cannot be paused for 12 hours
  • contraindication for treatment with atropin

研究组 & 干预措施

Atropin

Active Comparator

Atropin

干预措施: Atropine (Drug)

Placebo

Placebo Comparator

Saline

干预措施: Placebo (Drug)

结局指标

主要结局

insulin secretion

时间窗: tree hours

The insulin secretion during lightly elevated blood glucose during GLP-1 infusions with and without atropin administration is evaluated. Also the insulin secretion during lightly elevated blood glucose during a sham-feeding with and without atropin administration is evaluated.

次要结局

  • Plasma glucose(33 timepoints within tree hours)
  • Plasma PP(20 time points within tree hours)
  • Plasma glucagon(18 timepoints within tree hours)
  • Plasma GLP-2(18 time points within tree hours)
  • Plasma GIP(18 timepoints within tree hours)
  • Plasma GLP-1(18 time points within tree hours)

研究者

发起方
University Hospital, Gentofte, Copenhagen
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jonatan I Bagger

MD

University Hospital, Gentofte, Copenhagen

研究点 (2)

Loading locations...

相似试验